Cellular, Molecular and Biomedical Reports

Abbreviation: Cell. Mol. Biomed. Rep.

CODEN: CMBR

Cellular, Molecular and Biomedical Reports was launched by Global Sciences in 2021. This double peer-reviewed and indexed journal aim to provide a platform for researchers around the world to share their latest findings in all fields of  Cellular, Molecular and Biomedical Reports. Experimental, theoretical and applied original research studies in all fields of chemistry are welcomed for submission. The journal is Open Access with article processing charges and all articles published in this journal are freely available for readers online at https://www.cmbr-journal.com/ without a subscription and authors retain the copyright of their work.

CMBR is published Semiannual (online and in print= 2 Issues per year).

All submitted manuscripts are checked for similarity through a trustworthy software named iThenticateto be assured about their originality and then rigorously peer-reviewed by international reviewers.

 

 

Cellular, Molecular and Biomedical Reports is a scientific journal devoted entirely to all facets of pure and applied studies on all aspects of Cellular, Molecular and Biomedical sciences with emphasizing the latest techniques. Of course, The CMBR journal only accepts original, review, mini-review, or meta-analysis articles in the field of medicine or other organisms that have been used in medicine.

It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.

 

Aims and Scope

Cellular, Molecular and Biomedical Reports focuses on:

- All aspects of Cellular, Molecular and Biomedical Reports

- All aspects related to the different structures and functions of the cell and to its components (DNA, RNA, protein) are relevant to the scope of this journal

- DNA replication, transcription, nucleic acid-protein interaction, RNA processing, intracellular transport, protein biosynthesis are examples of topics within the Cellular, Molecular and Biomedical field

- Nuclear function, cytoskeleton and cell membrane interactions, transport of cellular products between different organelles fits in the Cellular, Molecular and Biomedical category.

 

The CMBR journal invites the Researchers or Scientists, Research scholars, Physicians, Academician, Industrialists, Lab Technologists, PG Students, Consultancies, etc., to employ this journal for publishing articles for the development of Cellular, Molecular and Biomedical Sciences.

 

Abstracting and Indexing:

Our review process is very strict and the papers not fulfilling the criteria are outright rejected. The journal has a wide network of very good academicians and researchers spread throughout the world and our referees are constantly working hard to maintain the journal standard. On global scale a large number of journals are present but we are keeping our promise to strictly adhere to the norms framed and so are vigilant to maintain the journal standard. All authors are hereby informed that the paper once accepted cannot be withdrawn at any condition. The Publishing Team of CMBR suggest you to not to submit same article to the multiple journals simultaneously. This may create a problem for you. Please wait for review report, which will take a maximum period of 10 to 20 days.

Membership

The editorial board members will be appointed by the editor-in-chief and confirmed by the Editorial Board. This will be a two-year renewable mandate.

Applications will be welcomed from interested individuals who are able to demonstrate a minimum of five years’ experience as a post-doctoral researcher, peer reviewer and author of published peer reviewed scholarly articles.  Applications meeting these minimum criteria will be referred to the editor-in-chief for further evaluation. The editor-in-chief may apply further criteria at her discretion. Applications must include suitable supporting documentation. Curriculum vitae will generally be sufficient. Any documentation must be in English. Successful applicants will be notified by managing editor. Decisions might generally take one month. 

Eligibility Criteria

Key qualities sought for the position of Editorial Board members include:

  • Possessing a doctoral degree in the specific subject related closely to the journal
  • Having an established record of scholarship (at least five manuscripts published in the last five years) in health policy and management
  • Fluent in academic and professional English
  • Working quickly and accurately to tight deadlines
  • Holding a job at a university or academic organization with a teaching or research position
  • Serving as a reviewer for IJHPM for two years and completed an adequate number of non-biased high quality reviews
  • Demonstrating high contribution in areas needed on the Editorial Board

Responsibilities

  • Working closely with the editor-in-chief to develop the journal’s editorial vision, processes, and practices
  • Demonstrating confidentiality and objectivity regarding the manuscripts and the review process
  • Providing expertise, advise, and assessment assistance to editor-in-chief
  • Helping the editor-in-chief identify potential reviewers
  • Helping the editor-in-chief decide which manuscripts to publish
  • Helping the editor-in-chief identify potential journal manuscripts for submission
  • Managing a minimum of six manuscript reviews per year in a timely manner
  • Recommending suitable reviewers to the editor-in-chief to ensure timely review process
  • Advising the editor-in-chief on matters of journal development
  • Encouraging article submissions to the journal from their network of colleagues and contacts
  • Providing occasional guest editorials or guest editing a special issue
  • Representing and promoting the journal at conferences

 

Cellular, Molecular and Biomedical Reports is a principle member and subscribes to the International Committee of Medical Journal Editors and World Association of medical Editors. We follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by International Committee for Medical Journal Editors (ICMJE), as well as the Committee on Publication Ethics (COPE) code of conduct for editors.

The ethical policy of Cellular, Molecular and Biomedical Reports (CMBR) is based on the Committee on Publication Ethics (COPE) guidelines and complies with International Committee of Medical Journal Editors (ICMJE) codes of conduct. The following guidelines should be read in line with the journal’s guide for authors. The statements confirm that confidentiality and fairness should be considered in all the CMBR procedures and interactions. Readers, authors, reviewers and editors should follow these ethical policies once working with CMBR.   

Editorial Policy

CMBR prevailing criteria for articles include the originality, high academic quality, and genuine interest to a wide international audience. The journal editorial team encourages the authors to pay close attention to the factors that will increase the likelihood of acceptance. Manuscripts that fall short of setting out the international debates and policy lessons are more likely to be rejected or returned to the authors for redrafting prior to being reviewed. Researchers who write about a specific health problem, intervention, or service should discuss the relevance of the analysis for the broader health system. Those evaluating health policies or health system performance should draw on relevant bodies of theory in their analysis; otherwise justify why they have not done so, instead of just presenting a narrative based on empirical data. CMBR supports the Open Access initiative. Abstracts and full texts (PDF format) of all articles published by CMBR are freely accessible to everyone immediately upon publication. 

Cellular, Molecular and Biomedical Reports is a principle member and subscribes to the International Committee of Medical Journal Editors and World Association of Medical Editors. We follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors (ICMJE), as well as the Committee on Publication Ethics (COPE) code of conduct for editors.

The ethical policy of the Cellular, Molecular and Biomedical Reports (CMBR) is based on the Committee on Publication Ethics (COPE) guidelines and complies with the International Committee of Medical Journal Editors (ICMJE) codes of conduct. The following guidelines should be read in line with the journal’s guide for authors. The statements confirm that confidentiality and fairness should be considered in all the CMBR procedures and interactions. Readers, authors, reviewers and editors should follow these ethical policies once working with CMBR. 

Policy statement – Conflict of Interest

Authors publishing in Cellular, Molecular and Biomedical Reports must declare all financial disclosures and conflicts of interest in the cover letter and on the title page of manuscripts submitted for publication. All submitted manuscripts must include a ‘competing interests’ section at the end of the manuscript listing all competing interests (financial and non-financial). Where authors have no competing interests, the statement should read “The authors have declared that no competing interests exist.” Editors may ask for further information relating to competing interests. Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists.

Policy statement – Human and Animal Rights

All studies submitted to Cellular, Molecular and Biomedical Reports for publication must be in compliance with institutional and international regulations for human and animal studies such as the Helsinki declaration. Human studies require ethics committee approval and informed consent which must be documented in your manuscript. Animal studies require ethics committee approval and must conform to international guidelines for animal research. Compliance with these requirements must be documented in your manuscript.  Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. A statement detailing compliance with guidelines and/or ethical approval must be included in the manuscript. For studies involving client-owned animals, authors must document informed client consent and adherence to a high standard (best practice) of veterinary care. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption). Further information and documentation to support this should be made available to Editors on request. Manuscripts may be rejected if the Editor considers that the research has not been carried out within an appropriate ethical framework. In rare cases, Editors may contact the ethics committee for further information.

Policy statement – Informed Consent

All human studies submitted for publication in Cellular, Molecular and Biomedical Reports require informed consent and ethics committee approval. If waiver of consent was granted by the ethics committee in the case of retrospective studies not impacting on patient confidentiality or patient rights, this must be clearly stated in the cover letter and manuscript. For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript. For all manuscripts that include details, images, or videos relating to individual participants, written informed consent for the publication of these must be obtained from the participants (or their parent or legal guardian in the case of children under 16) and a statement to this effect should appear in the manuscript. If the participant has died, then consent for publication must be sought from the next of kin of the participant. This documentation must be made available to Editors on request and will be treated confidentially. In cases where images are entirely unidentifiable and there are no details on individuals reported within the manuscript, consent for publication of images may not be required. The final decision on whether consent to publish is required lies with the Editor.

=====================================================================

CMBR CrossMark Policy

CrossMark is a multi-publisher initiative by the CrossRef Organization to provide a standard way for readers to locate the authoritative version of a document. Clicking on the CrossMark logo will provide the current status of a document and may also provide additional publication record information about the document.